Federal regulators are confronting a new twist in drug development: manufacturers that include software with the medicine to prod patients to take pills as directed, manage side effects or track how well a treatment works. The apps could boost the drugs' clinical value and provide a more personalized approach to managing chronic conditions such as depression, obesity and musculoskeletal problems.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
